Metropolis Healthcare Board to Consider Q2FY27 Results and Interim Dividend
Metropolis Healthcare Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Metropolis Healthcare Board to Consider Q2FY27 Results and Interim Dividend Metropolis Healthcare has scheduled a Board of Directors meeting for 3rd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the board will evaluate the declaration of an interim dividend on equity shares for FY26-27. In compliance with insider trading regulations, the company's trading window remains closed from 1st Oct'26 through 5th Nov'26 (both days inclusive).
Original exchange filing (PDF)
More announcements from Metropolis Healthcare Ltd
- Transcript of Q2 and H1 FY27 earnings conference call held on November 04, 2026 路 10 Nov 2026
- Schedule of Analyst / Institutional Investor Meeting 路 05 Nov 2026
- Link of the audio recording of the earnings conference call held on November 04, 2026 路 04 Nov 2026
- Press Release 路 04 Nov 2026
- Investor Presentation for the quarter and half year ended September 30, 2026 路 04 Nov 2026
- Board approves Interim Dividend 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 路 04 Nov 2026
- Metropolis Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
